52 research outputs found

    Prevalencia de candidiasis vaginal en una población obstétrica de bajo riesgo en Santander

    Get PDF
    ObjetivoConocer la prevalencia de candidiasis vaginal en embarazadas controladas desde atención primaria y ver si está aumentando con el paso del tiempo.DiseñoEstudio descriptivo, retrospectivo del universo de mujeres embarazadas.EmplazamientoZona Básica de Salud Cazoña (34.783 habitantes).SujetosToda la población obstétrica controlada en nuestro centro de salud desde 1992 a 1997, ambos inclusive.Mediciones y resultadosEstudio retrospectivo de las historias clínicas de todas las mujeres embarazadas captadas en nuestro centro de salud (878 embarazos). Descartados los derivados a tocólogo, abortos y partos prematuros, se han valorado 549 embarazos (62,30% del total) normales, de bajo riesgo, controlados hasta el final por atención primaria, con un rango de edad de 16-40 años. La prevalencia media de candidiasis es de un 18% (IC, 15,0-21,6). Su frecuencia aumenta a medida que se incrementa el número de gestaciones y disminuye a medida que aumenta la edad de la embarazada.ConclusionesLa prevalencia encontrada en nuestro estudio es de un 18%, y no está aumentando a medida que pasan los años.ObjectivesTo find the prevalence of vaginal candidiasis in pregnant women monitored through primary care and to see whether it is on the increase.DesignDescriptive and retrospective study of pregnant women.SettingCazoña Health District (34783 inhabitants).SubjectsThe entire obstetric population monitored by our health centre between 1992 and 1997 inclusive.Measurements and resultsRetrospective study of clinical histories of all the pregnant women seen at our health centre (878 pregnancies). After discounting those referred to obstetricians, abortions/ miscarriages and premature births, 549 normal low-risk pregnancies (62.30% of the total) were monitored to completion in primary care. The women's age range was 16 to 40. The mean prevalence of candidiasis was 18% (CI, 15.0-21.6). Its frequency increased as the number of pregnancies increased and dropped as the age of the pregnant women increased.ConclusionsPrevalence found in our study was 18% and did not increase as the years passed

    Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death

    Get PDF
    Systemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability in disease progression and prognosis. In the present study, we assess survival, causes of death, and risk factors of mortality in a large series of Spanish SSc patients. Consecutive SSc patients fulfilling criteria of the classification by LeRoy were recruited in the survey. Kaplan-Meier and Cox proportional-hazards models were used to analyze survival and to identify predictors of mortality. Among 879 consecutive patients, 138 (15.7%) deaths were registered. Seventy-six out of 138 (55%) deceased patients were due to causes attributed to SSc, and pulmonary hypertension (PH) was the leading cause in 23 (16.6%) patients. Survival rates were 96%, 93%, 83%, and 73% at 5, 10, 20, and 30 years after the first symptom, respectively. Survival rates for diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc were 91%, 86%, 64%, and 39%; and 97%, 95%, 85%, and 81% at 5, 10, 20, and 30 years, respectively (log-rank: 67.63, P < 0.0001). The dcSSc subset, male sex, age at disease onset older than 65 years, digital ulcers, interstitial lung disease (ILD), PH, heart involvement, scleroderma renal crisis (SRC), presence of antitopoisomerase I and absence of anticentromere antibodies, and active capillaroscopic pattern showed reduced survival rate. In a multivariate analysis, older age at disease onset, dcSSc, ILD, PH, and SRC were independent risk factors for mortality. In the present study involving a large cohort of SSc patients, a high prevalence of disease-related causes of death was demonstrated. Older age at disease onset, dcSSc, ILD, PH, and SRC were identified as independent prognostic factors

    Registro Español de Trasplante Cardiaco. XXXI Informe Oficial de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología

    Get PDF
    Introducción y objetivos Se presentan las características clínicas y los resultados de los trasplantes cardiacos realizados en España con la actualización correspondiente a 2019. Métodos Se describen las características clínicas y los resultados de los trasplantes cardiacos realizados en 2019, así como las tendencias de estos en el periodo 2010-2018. Resultados En 2019 se realizaron 300 trasplantes (8.794 desde 1984; 2.745 entre 2010 y 2019). Respecto a años previos, los cambios más llamativos son el descenso hasta el 38% de los trasplantes realizados en código urgente, y la consolidación en el cambio de asistencia circulatoria pretrasplante, con la práctica desaparición del balón de contrapulsación (0, 7%), la estabilización del uso del oxigenador extracorpóreo de membrana (9, 6%) y el aumento de los dispositivos de asistencia ventricular (29%). La supervivencia en el trienio 2016-2018 es similar a la del trienio 2013-2015 (p = 0, 34), y ambas mejores que la del trienio 2010-2012 (p = 0, 002 y p = 0, 01 respectivamente). Conclusiones Se mantienen estables tanto la actividad del trasplante cardiaco en España como los resultados en supervivencia en los últimos 2 trienios. Hay una tendencia a realizar menos trasplantes urgentes, la mayoría con dispositivos de asistencia ventricular. Introduction and objectives: The present report describes the clinical characteristics and outcomes of heart transplants in Spain and updates the data to 2019. Methods: We describe the clinical characteristics and outcomes of heart transplants performed in Spain in 2019, as well as trends in this procedure from 2010 to 2018. Results: In 2019, 300 transplants were performed (8794 since 1984; 2745 between 2010 and 2019). Compared with previous years, the most notable findings were the decreasing rate of urgent transplants (38%), and the consolidation of the type of circulatory support prior to transplant, with an almost complete disappearance of counterpulsation balloon (0.7%), stabilization in the use of extracorporeal membrane oxygenation (9.6%), and an increase in the use of ventricular assist devices (29.0%). Survival from 2016 to 2018 was similar to that from 2013 to 2015 (P = .34). Survival in both these periods was better than that from 2010 to 2012 (P = .002 and P = .01, respectively). Conclusions: Heart transplant activity has remained stable during the last few years, as have outcomes (in terms of survival). There has been a trend to a lower rate of urgent transplants and to a higher use of ventricular assist devices prior to transplant

    Measurement of CP asymmetries and branching fraction ratios of B− decays to two charm mesons

    Get PDF
    The CPCP asymmetries of seven BB^- decays to two charm mesons are measured using data corresponding to an integrated luminosity of 9fb19\text{fb}^{-1} of proton-proton collisions collected by the LHCb experiment. Decays involving a D0D^{*0} or DsD^{*-}_s meson are analysed by reconstructing only the D0D^0 or DsD^-_s decay products. This paper presents the first measurement of ACP(BDsD0)\mathcal{A}^{CP}(B^- \rightarrow D^{*-}_s D^0) and ACP(BDsD0)\mathcal{A}^{CP}(B^- \rightarrow D^{-}_s D^{*0}), and the most precise measurement of the other five CPCP asymmetries. There is no evidence of CPCP violation in any of the analysed decays. Additionally, two ratios between branching fractions of selected decays are measured.The CP asymmetries of seven B^{−} decays to two charm mesons are measured using data corresponding to an integrated luminosity of 9 fb1^{−1} of proton-proton collisions collected by the LHCb experiment. Decays involving a D0^{*0} or Ds {D}_s^{\ast -} meson are analysed by reconstructing only the D0^{0} or Ds {D}_s^{-} decay products. This paper presents the first measurement of ACP \mathcal{A} ^{CP}(B^{−}Ds {D}_s^{\ast -} D0^{0}) and ACP \mathcal{A} ^{CP}(B^{−}Ds {D}_s^{-} D0^{∗0}), and the most precise measurement of the other five CP asymmetries. There is no evidence of CP violation in any of the analysed decays. Additionally, two ratios between branching fractions of selected decays are measured.[graphic not available: see fulltext]The CPCP asymmetries of seven BB^- decays to two charm mesons are measured using data corresponding to an integrated luminosity of 9 fb19\text{ fb}^{-1} of proton-proton collisions collected by the LHCb experiment. Decays involving a D0D^{*0} or DsD^{*-}_s meson are analysed by reconstructing only the D0D^0 or DsD^-_s decay products. This paper presents the first measurement of ACP(BDsD0)\mathcal{A}^{CP}(B^- \rightarrow D^{*-}_s D^0) and ACP(BDsD0)\mathcal{A}^{CP}(B^- \rightarrow D^{-}_s D^{*0}), and the most precise measurement of the other five CPCP asymmetries. There is no evidence of CPCP violation in any of the analysed decays. Additionally, two ratios between branching fractions of selected decays are measured

    GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Get PDF
    Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments

    Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death

    No full text
    Systemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability in disease progression and prognosis. In the present study, we assess survival, causes of death, and risk factors of mortality in a large series of Spanish SSc patients. Consecutive SSc patients fulfilling criteria of the classification by LeRoy were recruited in the survey. Kaplan-Meier and Cox proportional-hazards models were used to analyze survival and to identify predictors of mortality. Among 879 consecutive patients, 138 (15.7%) deaths were registered. Seventy-six out of 138 (55%) deceased patients were due to causes attributed to SSc, and pulmonary hypertension (PH) was the leading cause in 23 (16.6%) patients. Survival rates were 96%, 93%, 83%, and 73% at 5, 10, 20, and 30 years after the first symptom, respectively. Survival rates for diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc were 91%, 86%, 64%, and 39%; and 97%, 95%, 85%, and 81% at 5, 10, 20, and 30 years, respectively (log-rank: 67.63, P < 0.0001). The dcSSc subset, male sex, age at disease onset older than 65 years, digital ulcers, interstitial lung disease (ILD), PH, heart involvement, scleroderma renal crisis (SRC), presence of antitopoisomerase I and absence of anticentromere antibodies, and active capillaroscopic pattern showed reduced survival rate. In a multivariate analysis, older age at disease onset, dcSSc, ILD, PH, and SRC were independent risk factors for mortality. In the present study involving a large cohort of SSc patients, a high prevalence of disease-related causes of death was demonstrated. Older age at disease onset, dcSSc, ILD, PH, and SRC were identified as independent prognostic factors
    corecore